CAPR

NASDAQ · Biotechnology

Capricor Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$29.10

-2.07 (-6.64%)

CAPR News1 articles

Capricor Shares Gain Ahead of Key Duchenne Data and Financial Update

Capricor Therapeutics shares advanced 7.6% as the company prepares to release quarterly results and full Phase 3 data for its Duchenne muscular dystrophy drug deramiocel on March 12.